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MIR: 75 YEARS OF RADIOLOGY EXPERIENCE

In the early 1900s, radiology was considered by most medical
practitioners as nothing more than photography. In this 75th
year of Mallinckrodt Institute's existence, the first of a three-part
series of articles will chronicle the rapid advancement of radiology at Washington University and the emergence of MIR as a
world leader in the field of radiology.
THE METABOLISM OF THE DIABETIC HEART

More diabetic patients die from cardiovascular
disease than from any other cause. Researchers in
the Institute's Cardiovascular Imaging Laboratory
are finding that the heart's metabolism may be one
of the primary mechanisms by which diseases such as
diabetes have a detrimental effect on heart function.

VIRTUAL C0L0N0SC0PY: A LIFESAVING TECHNOLOGY

More than 55,000 Americans die each year from
cancers of the colon and rectum. As part of the
National CT Colonography Trial, MIR clinical
researchers are evaluating new noninvasive
technologies to make screening easier, faster,
and more comfortable for the patient while
providing diagnostic accuracy.

UTERINE FIBROID EMBOLIZATION

More than 5 million American women suffer
with symptomatic uterine fibroids, and each year
approximately 250,000 women undergo surgery to
alleviate the fibroid-associated pain. Interventional
radiologists at Mallinckrodt Institute provide a
uterus-sparing treatment option that shrinks the
fibroids and relieves pressure on adjacent organs.

m
Visit the MIR web site at
www.mir.wustl.edu

ON THE COVER Colon cancer is the second most deadly cancer in the United States, but
health professionals like Christine Menias, MD, and research assistant Ruth Holdener
(right) are working to increase awareness about colon cancer and the need for diagnostic
screening. Photograph by Tim Parker.

►TNEWS
Matching
Program results
announced

Siteman Cancer
Center accepted
into NCCN

In July, 18 physicians
will begin their first year of
training in diagnostic radiology. The 2006-2007 trainees
come from these institutions:
•Case Western Reserve
University School of
Medicine, Cleveland, Ohio
•University of Alabama
School of Medicine,
Birmingham
•University of Virginia
School of Medicine,
Charlottesville
•Duke University School
of Medicine, Durham,
North Carolina
•University of Texas
Medical School at Houston
•Washington University
in St. Louis School of
Medicine
•Yale University School
of Medicine, New Haven,
Connecticut
•University of California,
San Francisco School
of Medicine
•Columbia University
College of Physicians
and Surgeons, New York
City, New York
•Vanderbilt University
School of Medicine,
Nashville, Tennessee
•University of Pennsylvania
School of Medicine,
Philadelphia
•University of Michigan
School of Medicine,
Ann Arbor.

The Alvin J. Siteman
Cancer Center (SCC),
housed in the Center for
Advanced Medicine at Washington University Medical
Center, is now a member of
The National Comprehensive
Cancer Network (NCCN).
As an NCCN member, the
SCC will be involved in the
planning, development, and
validation of therapies and
guidelines representing the
future of cancer care. The
NCCN is an alliance of 20
nationally acclaimed cancer
centers dedicated to improving the quality, efficiency,
and effectiveness of
oncology practice.

WUSM retains
high national
ranking
Since 1987, U.S. News &
World Report has issued an
annual ranking of professional and graduate schools.
Washington University in
St. Louis School of Medicine
(WUSM) consistently has
placed in the top 10 schools
and since 1998 has ranked
first in student selectivity,
based on both college gradepoint averages and MCAT
scores. According to the
magazine's April 3, 2006
survey, WUSM ranked fourth
overall among researchoriented medical schools.
The top schools in order are
Harvard University; Johns
Hopkins University; University of Pennsylvania; WUSM

and University of California,
San Francisco (tie); Duke
University; Stanford
University and University
of Washington (tie); Yale
University; and Baylor College of Medicine. The U.S.
News rankings are online at
www.usnews.com/usnews/
rankguide/rghome.htm.

Wilson Award
presented
The 38th annual Hugh
M. Wilson Award for Meritorious Work in Radiology
was presented on May 19 to
Alexander Ho, a fourth-year
medical student. Traditionally
given at the senior program
following the Washington
University in St. Louis
School of Medicine (WUSM)
commencement exercises,
the Wilson Award honors
Mallinckrodt Institute's second director, an advocate of
the advancement of education.
Ho worked with Daniel
Brown, MD, associate professor of radiology and of
surgery, in the Institute's
interventional radiology
section. Prior to the start of
the interventional radiology
elective, Ho researched
published information on
chemoembolization and
neuroendocrine tumors. He
also initiated a database of
all patients with neuroendocrine tumors who were
treated at the Washington
University Medical Center
from 1991 to 2005. According
to Brown, Ho's review was
"extraordinary in its depth
and has led to some important findings that may
change the way patients
with this disease process
are treated."

Under Brown's mentorship,
Ho was principal investigator
on the project "Long term
outcomes of hepatic arterial
chemoembolization for neuroendocrine malignancy," for
which he drafted the abstract
and manuscript—which has
been submitted for presentation
at the annual Radiological
Society of North America
meeting in Chicago and also I
is being submitted to the jour- I
nal Radiology for publication. (
Ho will begin his first year >
of diagnostic radiology resi- i
dency at Mallinckrodt Institute \
in July 2007, after completing a»
preliminary training year in
internal medicine at the University of California, San Diego.

Workshops
address
radiology clinical fj
trials training
Approximately 25 participants attended the Clinical
Trials Methodology Workshop.
sponsored by the Radiological
Society of North America
(RSNA), held in January in
Phoenix, Arizona. Barry Siegel.
MD, professor of radiology
and of medicine, and Delpliine
Chen, MD, nuclear medicine
resident, represented
Mallinckrodt Institute.
This inaugural session s
goal was to develop the
groundwork for a series of
workshops for radiology,
nuclear medicine, and radi; tior
oncology faculty, fellows,
and senior residents as the
develop careers in researcl
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According to workshop
organizers, "there is a need
to train radiologists to conduct clinical trials. Imaging
is a critical part of many
drug trials, and third-party
payers and others also are
beginning to demand much
more rigorous data to justify
clinical decisions."
The RSNA training sessions will be based on the
successful, long-running
clinical trials workshops
sponsored by the American
Association for Cancer
Research and the American
Society of Clinical Oncology.
Participants will receive
training in protocol development for the clinical evaluation
of imaging modalities, with
courses including didactic
sessions, self study,
protocol synthesis process,
one-on-one mentoring,
and discussion sessions.
For more information
about the workshop and
how to attend future
sessions, go online at
www.rsna.org/Publications/
rsnanews/april06/
clinical_april06. cfm.

Faculty
receive kudos
The following Mallinckrodt Institute clinicians and
researchers were recognized
for their many achievements:
• Maurizio Corbetta, MD,
professor of neurology, of
radiology, and of anatomy
and neurobiology,
received the American
Academy of Neurology's
(AAN's) Norman
Geschwind Prize for his
outstanding research in
the field of behavioral
neurology. The award
was presented at the
AAN's annual meeting in
April in San Diego.
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Career Fair
Washington University in St. Louis School
of Medicine (WUSM) held its first Career
Fair for Clinical and Research on May 6 in
the Farrell Learning and Teaching Center.
Kim Whitling (shown at far left in top
photo), manager, administrative services,
represented Mallinckrodt Institute at the
event that provided information about
clinical and research opportunities in
various WUSM departments. An estimated
150 attendees submitted job applications.

' William McAlister, MD,
professor of radiology
and of pediatrics, was a
recipient of one of three
Distinguished Service
Awards presented by
Washington University
in St. Louis School of
Medicine at the Reunion
2006 award ceremony
in May.
• Kathleen McDermott,
PhD, assistant professor of
psychology and of radiology,
was named an Outstanding Faculty Mentor by the
Graduate Student Senate
of Washington University

in St. Louis. The award,
established in 1999, honors faculty who make a
significant contribution
to the quality of life
and professional development of Arts & Sciences
graduate students.
1

Marcus Raichle, MD,
professor of radiology, of
neurobiology, and of
neurology, was awarded
the honorary degree of
Doctor of Science by the
University of Chicago.

The following is an excerpt
from the nominating statement: "Widely considered the
father of cognitive neuroscience, Professor Raichle's
technical contributions to
the field of neuroimaging
and his research contributions
.. .have revolutionized the
study of brain and behavior."
Raichle also received the
2006 Distinguished Alumni
Award from his alma mater,
the University of Washington
in Seattle.

early 111 years ago (November 8.1895, to be precise)
Wilhelm Conrad Rontgen, a physics proiessor, was in his
darkened laboratory in Wurzberg, Germany, experimenting
with the action of electric energy in partially evacuated glass tubes.
Alter he noticed a glow emanating from
the far corner of the lab, Rontgen
conducted a series of experiments,
which culminated with passing
his hand between a fluorescing
screen and the tube and then
seeing what appeared to be
a shadow of the bones in his
hand. He verified these
observations by capturing
the bone shadow
images onto photographic plates. The
subsequent publishing
of Rontgen's data in
the Wurzberg PhysicoMedical Society's scientific
journal and in newspapers
worldwide heralded the startling
discovery of the new, unknown rays—
'^rodtlnstm^ referred
to as X rays.
The following article is the first of three installments that will follow
the history of radiology at Washington University in St. Louis and the
establishment of Mallinckrodt Institute of Radiology (MIR). In this 75th
year of MIR's existence, it is important to honor our past, highlight the
present, and ponder our future. Information for this and subsequent
articles was condensed from several sources, including the booklet
Mallinckrodt Institute of Radiology 50th Anniversary and an informal
text prepared by Sam Merenda. MD, a St. Louis radiologist.

W
RADIOLOGY AT
WASHINGTON UNIVERSITY:

PRE-MIR
Functioning X-ray equipment
was in place (known as the Photographical Roentgen Ray Department)
at Washington University before
1900. However, the University's
X-ray service actually came into
existence in 1910—just 15 years
after Rontgen's discovery—at the
Washington University School of
Medicine (WUSM), which was affiliated with the Washington University
Hospital on Jefferson Avenue.

W m X/ /^ m &
The X-ray service was called the
"Actinographic Laboratory" [no
data is available as to why it was
so named] and was directed by
Russell Carman, MD, a pioneer in
the clinical use of X rays (particularly in gastroenterology). Carman's academic title was "lecturer
in roentgenography." Following a
reorganization of WUSM departments in 1912 and 1913, which
resulted in the X-ray service being

assigned to the Department of
Surgery, Carman became an
instructor in roentgenology. Carman left the University in late 1913
to become head of radiology at the
Mayo Clinic in Rochester, Minnesota,
where he remained until his death
in 1926. Charles Mayo, MD, and
many other influential physicians
at that time considered Carman "the
leading radiologist in the country."
Walter Mills, MD, a graduate of
the Marion Sims-Beaumont College
of Medicine (later known as
Saint Louis University School of
Medicine), succeeded Carman as
head of radiology. He had given
up a private general practice in
Webster Groves, Missouri, to study
gastroenterology in Europe. Mills
was later affiliated with WUSM and
the Jefferson Avenue hospital
where he worked to develop diagnostic techniques for clinical exams,
especially the digestive system.
He had particular expertise in
fluoroscopy and was a pioneer in
developing diagnostic imaging
techniques. Following Carman's
departure in 1913, Mills became
head of WUSM radiology.
In 1914, X-ray activities were
moved from the Jefferson Avenue
hospital to a Kingshighway Boulevard facility that was affiliated with
WUSM and Barnes Hospital. Two
rooms (called the X-ray Laboratory),
then considered adequate for the
fledgling service, was established
on the second floor of the hospital.
A local newspaper's mention of the
relocation called the lab "an elaborate photographic gallery for
taking X-ray, autochrome, and
ordinary pictures."
A piece of diagnostic equipment,
an X-ray generator that had been
used at the Jefferson Avenue facility
by Carman in his fluoroscopic
investigations of the gastrointestinal
tract, was moved to the new location and subsequently used by
other groups in some innovative
applications: pyleographic images,
MALLINCKRODT INSTITUTE OF RADIOLC
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(left to right) doctors

Glover Copher, Evarts
Graham, Warren Cole, and
Sherwood Moore.
(below) Circa 1914—X-ray
generator used in the animal
lab to produce X rays as
cholecystography was being

using sodium iodide, of the kidney,
ureters, and bladder; first arteriogram
on record; and the evaluation of
animal testing that resulted in the
development of cholecystography.
As radiographic usage became
more widespread, the second-floor
quarters soon became obsolete; a
new radiology department was
being considered.
In 1917, Sherwood Moore, MD,
joined Mills at WUSM as a codirector of the new lab. Moore had a
broad medical background, ranging
from training in obstetrics and
gynecology to surgery to radiology.
At the time, radiology did not
have departmental status, as it was
still considered a "new service." In
institutions across the country, the
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service most commonly fell under the
jurisdiction of the
Surgery or Internal
Medicine departments. According to
Moore (in a later
article in the January
1940 Washington
University Medical
Alumni Quarterly),
"It is interesting that
at the time, although
the X ray was almost
twenty years old,
the press and the
general public
regarded the X-ray
apparatus as a specialized camera and
the radiologist as a photographer;
radiology continued to occupy
this lowly position in medicine for
many years before it was recognized
as an independent field."
Meanwhile, the X-ray Laboratory
was definitely moving forward:
The first high-voltage (or deep)
X-ray therapy equipment was
installed on March 14, 1922, and
the first case involved treating a
patient with recurrent cancer of
the neck. And on February 10, 1922,
X-ray film, instead of radiographic
plates, was used for the first time
for general diagnostic work.

WE OWE IT ALL TO
GALLBLADDER RESEARCH

In the 1920s, Evarts Graham,
MD, professor of surgery and
director of the WUSM Department
of Surgery, became interested in
developing a test for diagnosing
gallbladder disease. Scientific
studies at that time showed that a
healthy gallbladder produced
concentrations of bile and certain
compounds excreted almost entirely

in the bile. In order to visualize the
gallbladder, a chemical compound
had to be developed that would
concentrate in bile, be visible by
radiography, and be safe for the
patients. And certain biochemical
investigations suggested there

Mallinckrodt Institute of Radiology

>o
might be a way to visualize the
gallbladder by X ray—although it
had never been done. Graham and
Moore (WUSM's only radiologist at
the time)—along with surgeons
Warren Cole, MD, and Glover
Copher, MD, began a series of
studies in animal models.
The researchers, working with
a local chemical company, developed
and tested approximately 90 compounds, 13 of which demonstrated
the ability to concentrate in the
gallbladder. The first successful
image of a canine gallbladder
was obtained in November 1923.
However, subsequent attempts
to reproduce other images failed;

mm

Cirta 1924—first visualization of a
human gallbladder

the researchers discovered that
the visualization only worked if
the subject was fasting. The first
cholecystogram (as the image was
now called) of a human gallbladder
—a student nurse volunteered
for the study—was performed in
February 1924.
By 1927 cholecystography, this
most important contribution in the
field of diagnostic radiology, was
universally accepted. Graham and
Moore (who had become sole
director of radiology after Mills
died in 1924) were convinced that
radiology had developed to the
point that it merited departmental
status at WUSM. The lab's quarters
on the second floor of Barnes
Hospital soon became crowded,
and the equipment that had been
the best available in 1914 became
obsolete. Advancement in the field
of radiology was so rapid and the
demand for its services so great
that a change had to be made.

ESTABLISHING A
DEPARTMENT OF RADIOLOGY
Graham agreed that radiology
should become a department
separate from surgery. He
actively began to promote radiology as a recognized specialty
and to establish radiology at
WUSM. In 1927, Graham and
McKim Marriott, MD, then Dean
of WUSM, petitioned the Rockefeller Foundation for support in
establishing a Department of
Radiology. The Foundation agreed
to endow an institute of radiology,
the first ever to be established in
the United States. However, a
proviso went with the endowment:
None of the money could be used
for construction. There was now
money for research, but no place
in which to conduct that research.

B
BRICKS AND M
MORT;
IORTAR
Graham and Marriott returned
to St. Louis and approached
Edward Mallinckrodt, Sr., head of
Mallinckrodt Chemical Works and
a well-known philanthropist, for
the funds to build a facility to
house the department. Mallinckrodt
agreed to fund the construction.
Mallinckrodt, Sr. died in 1928, but
Edward Mallinckrodt, Jr. sustained
his father's commitment by providing
additional funds to continue construction of Mallinckrodt Institute
of Radiology.
The Institute's cornerstone was
laid in October 1930. At completion,
MIR was a nine-story building
(eight floors plus a basement)—
the vertical configuration of the
building was considered unique
for the times and still is today, as
most radiology departments are
arranged in a horizontal format.
Initially most of the building was
not occupied, but with the dramatic growth of radiology in the
1930s and '40s, the additional
space would allow the department
to expand.
Routine radiography began in
August 1931. An additional fund for
equipment was provided by John
Queeny, a St. Louis businessman,
and his son Edgar. Installation of
the new X-ray equipment began in
July 1931, and the transfer of other
equipment to the new facility was
completed in September 1932.
MIR's beginning was a combination of Graham's and Moore's
ingenuity, the Rockefeller
Foundation's support, and the
Mallinckrodt family's generosity.
At the time, Mallinckrodt Institute
was one of five—and the largest—
of such institutions in the world,
plus it was centrally located in the
area of the hospital it served.

MALLINCKRODT INSTITUTE OF RADIOLOGY

Circa 1940s—doctors
Wendell Scott (left)
and Sherwood Moore
in a fourth-floor
radiology suite.

RADIOLOGY AT
37ie /93QJ

MIR

When the Institute opened in
1931, there were four radiologists
(including Moore, the first MIR
director) and a physicist on staff.
Patient services were assigned as
follows:
• Ground floor—Radiotherapy,
including a waiting room
• 1st floor—General offices and
viewing room
• 2nd floor—General X ray
• 3rd floor—Cystoscopy and
surgical radiology
• 4th floor—Fluoroscopy and
photography
• 5th and 6th floors—Shell space
• 7th floor—Biological research
• 8th floor—Film storage.
A steady increase in clinical
volume at Washington University
Medical Center, expanded experience with radiology techniques,
and new procedures developed
from research all contributed to the
Institute's tremendous growth in
the 1930s and into the '40s. In 1936,
Jean Kieffer, a self-taught medical
technician and radiographer at the
Institute, developed the principles
of body section radiography,
involving the synchronous movement of an X-ray tube and film in
opposite directions to image a
small "slice" of the body. The
resulting instrument, called a
laminagraph, was the forerunner
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of computed
tomography
and magnetic
resonance
imaging.
Around that
same time,
Wendell Scott,
MD, the first
assistant of
radiology at MIR, developed
roentgen kymography, a method
of recording the movements of
various organs and structures on
a single X-ray film. In July 1937,
the first three-year program for the
training of physicians to become
radiologists eligible for certification
by the American Board of Radiology
was established; William Burton,
MD, and Allan Phillips, MD,
were the first trainees at MIR.
In 1938, University and MIR
leaders agreed that applying
nuclear physics (a new and rapidly
advancing field) to the areas of
medicine and biology held great
promise for radiology research. A
cyclotron, to be designed and built
specifically for medical use, was
funded in part by a grant from the
Rockefeller Foundation. Due to
insufficient space at the Medical
Center, the cyclotron was
constructed and housed on the
University's main campus (known
as the Hilltop Campus).

9he /940J
Isotopes of cobalt, iron, and
phosphorous, produced by the
cyclotron, were available for medical use at WUSM in March 1942.
In 1943, at the request of the United
States government, the cyclotron
was used during World War II
to produce plutonium for the
Manhattan Project.

In 1945, Martin Kamen, a
research chemist and a codiscoverer of carbon 14, joined the MIR
staff. He developed a laboratory of
basic research in the field of intermediary metabolism. The United
States War Department released a
small amount of radioactive carbon
14 to the Medical Center (and to
the Institute) for cancer research.
A Cobalt 60 unit, used to
deliver higher energy radiation
therapy, was installed on the
Institute's ground floor in 1948.
Radiologists collaborated with
physicians from the Department
of Obstetrics/Gynecology in using
Cobalt 60 to treat patients with
gynecological cancer.
Realizing the need to improve
angiographic techniques, Scott
envisioned capturing a series of
images in rapid sequence as contrast media circulated through
organs or vessels. In 1949, he
developed the rapidograph, which
greatly improved angiography, by
adapting a Fairchild A-5 aerial
camera used during World War II.
In July 1949, Moore retired as
director of the Institute and was
succeeded by Hugh Wilson, MD,
a WUSM graduate. Wilson, an MIR
staff member from 1931 to 1934,
was chairman of Yale University's
Department of Radiology when he
was asked to become director
of Mallinckrodt Institute. Shortly
after his arrival, Wilson defined his
goals for the Institute: establish
radiological subspecialties and
emphasize education.
Editor's note: The second installment ofMIR's history will focus
on the 1950s, '60s, and '70s—
decades that involved groundbreaking developments in
radiology technology as well as
rapid expansion at the Medical
Center and at MIR. (Special thanks
to Sue Day, in MIR's abdominal
imaging section, for sharing the
Merenda manuscript.)

The Metabolism of the
Diabetic Heart:

Not Just a Bystander in Heart Disease
by Candace O'Connor

More patients with diabetes mellitus die from cardiovascular disease than from any other cause. And the number of
diabetic patients in the United States is rising rapidly: from
14 million in 2000 to a projected 18 million by 2010. Clearly,
finding the underlying reasons for heart problems in these
patients is critically important—and for years scientists have
been studying various aspects of this problem, including the
role played by atherosclerosis, hypertension, and vascular
changes in coronary artery disease.
"But physicians and researchers
have long ignored the metabolism
of the heart," says Robert Gropler,
MD, director of Mallinckrodt
Institute of Radiology's (MIR's)
Cardiovascular Imaging Laboratory.
"They have looked at it as a kind
of innocent bystander in what
happens—not really much of a
contributor to what goes on.
But we're learning that it is
much more than just a
bystander; in fact, the heart's
metabolism may well be
one of the primary mechanisms by which various
disease processes, in this
case diabetes, have a
detrimental effect on
heart function."

Gropler and his colleagues
in the Cardiovascular Imaging
Laboratory—most notably, Pilar
Herrero, MS, a research associate
professor of radiology—and
key collaborators from other
departments—particularly
endocrinologist Janet McGill,
MD, of the Department of Internal
Medicine—have been investigating
this problem. Recently, they
published two papers in the
Journal of the American College
of Cardiology: the first, in July
2005, demonstrating that high
glucose levels impair blood flow to
the diabetic heart; and the second,

•Ex

:f,:

[in February 2006, examining the
| impact of increased myocardial
fatty acid metabolism on patients
with type 1 diabetes and, specifii cally, on their cardiac function.
This work was funded by the
'- National Institutes of Health in the
form of a program project grant
from the National Heart, Lung,
and Blood Institute; Michael
Welch, PhD, codirector of MIR's
Division of Radiological Sciences,
is principal investigator.
The investigators began their
work within a research context
particularly conducive to this kind
of project. At Washington University in St. Louis School of Medicine,
scientists have long engaged in a
major effort to better understand
diabetes: its basic molecular
biology, how it affects patients,
and evaluating new treatment
strategies. Some University-based
research groups also have focused
on studying how the heart's
increased fat metabolism may
be detrimental.

Symptoms of Diabetes
lecent studies indicate that early
ietection of diabetes symptoms and
rly treatment can decrease the chance
' developing complications associated
vith diabetes.
1
Frequent urination
ixcessive thirst
' Extreme hunger
Unusual weight loss
Increased fatigue
1
Irritability
'Blurred vision.
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At MIR, Gropler
and his group also
had a rich history
of positron-emission
tomography (PET)
expertise to draw
upon [PET was
developed at MIR in
the 1970s.], including the ability to
make novel radiopharmaceuticals as
carbon-11 palmitate
and carbon-11 glucose.
In addition, work
led by Herrero
pioneered the primary
imaging approach
that allows the
researchers to use

"...researchers have long ignored
the metabolism of the heart..."
PET and these radiopharmaceuticals to
quantify cardiac fat and
glucose metabolism.
"Our ability to
conduct these in-depth
measurements of
myocardial substrate
metabolism that
aren't being done in
other labs worldwide
is really a tribute to
the quality of the
imaging infrastructure
at MIR and to the
whole PET enterprise," says Gropler,
professor of radiology,
of medicine, and of
biomedical engineering. "Because of this
unique depth and breadth, we can
do these highly complex studies
that permit a comprehensive
and noninvasive assessment of
myocardial substrate use."

(Above) Theresa Butler, RN, research nurse coordinator,
prepares the study volunteer for PET scanning.
(Below) Butler is injecting C-l 1 acetate into an IV in
the volunteer's left arm. C-l 1 acetate measures the
heart's oxygen usage.

The Metabolism of the
Diabetic Heart:

Not Just a Bystander in Heart Disease

Types of Diabetes
Type 1 —previously called
insulin-dependent diabetes mellitus or juvenile-onset diabetes.
Develops when the body's
immune system destroys pancreatic beta cells, the body's only
cells that produce the hormone
insulin that regulates blood
glucose. Patients with type 1
diabetes receive insulin via
injection or a pump.
Type 2—previously called
noninsulin-dependent diabetes
mellitus or adult-onset diabetes.
Accounts for approximately
90 percent to 95 percent of all
diagnosed cases of diabetes.
Associated with older age, obesity,
family history of diabetes, history
of gestational diabetes, impaired
glucose metabolism, physical
inactivity, and race/ethnicity.
Gestational diabetes—a form
of glucose intolerance diagnosed
in some women during pregnancy. More common among
obese women and those with
a family history of diabetes.
During pregnancy, gestational
diabetes requires treatment to
normalize maternal blood glucose levels to avoid complications to the infant.
Other types—result from
specific conditions such as
maturity-onset diabetes of youth,
surgery, drugs, malnutrition,
infections, and other illnesses.
Such types of diabetes account
for 1 percent to 5 percent
of all diagnosed cases.
Excerpted from the American
Diabetes Association Web site
at wwwxliabetes.org.

10

Gropler and his colleagues
decided to build on the University's
existing research base by looking
at heart metabolism in diabetic
patients. They also had another
reason to target this issue: a wealth
of data in animal models showing that the diabetic heart becomes
overly dependent on fats and loses
its ability to process a range of
other substrates, such as glucose
or lactate. Unfortunately, this
flexibility is the key to heart health.

In fact, he adds, the ratio of fat
usage by the diabetic heart changes
dramatically. Ordinarily, it might
represent 60 percent or 70 percent
of the various energy substrates,
with another 20 percent of glucose,
15 percent of lactate, and a tiny
amount of amino acid usage—
but now 90 percent of the heart's
substrate usage is fat. Other
researchers at the University
currently are performing novel basic
research into why this change occurs.

diabetic heart becomes
overly dependent on fats...
Why does this shift to fatty acid
dependency occur? It is caused by
what is happening elsewhere in the
diabetic body. Because of their
insulin resistance, diabetic patients
develop very high levels of fat in
the blood, either in the form of free
fatty acids or triglycerides. Day
after day, those fats travel through
the blood to the heart.
"And the heart is like the family
dog," says Gropler. "It will eat
whatever is put in front of it, so the
heart starts consuming these fats at
the expense of other substrates,
such as glucose. That sets off
a whole cascade of events within
the heart muscle that changes the
metabolism of that muscle and
also can change other processes
within the heart—affecting how
it contracts, survives an
ischemic insult, and so on."

Gropler and his colleagues
chose to look at another aspect of
the problem: With most of these
findings from animal models,
what exactly was happening in the
human heart? They knew that glucose metabolism was down but did
not have much data to prove that
fat metabolism was accelerated.

"So that's what
our study was based
[on," says Gropler.
"In diabetic hearts,
do we see this shift
in metabolism to
predominantly fats,
and could we begin
to understand why
that was occurring,
even obtaining
data to suggest
that it was this fat
delivery problem?"
They decided to
begin with a proofof-concept study,
comparing a group
of young, healthy
type-1 diabetic
patients to agematched and
gender-matched
volunteers without
diabetes. The
researchers ensured
that glucose and
insulin levels were similar between
the two groups and then used PET
to measure the blood flow, oxygen
usage, glucose metabolism,
and fatty acid metabolism in all
of the study participants.
"We found that the
diabetic participants
were burning three
times as much fat as the
ones without diabetes,
and the data suggested
that this was being
driven primarily by
the increased fat
delivery to the
heart muscle,"
says Gropler.

"-:;■'^i
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Robert Gropler, M.D.

"This increased delivery caused
the heart to rev up its oxidative
machinery to burn the fat. A
byproduct of that increased fat
burning, known as reactive oxygen
species, may ultimately damage the
machinery, leading
to a decline in the
capacity of the heart
to burn the fats it
takes up. As a
consequence, fats
accumulate in the
heart, initiating
a process called
'lipotoxicity.'"
As a concept,
lipotoxicity is
relatively new and
currently is being investigated as to
its relevancy in humans, though its
impact has already been shown by
Washington University investigators in numerous animal models.

Robert Gropler, MD, and Piiar Herrero, MS, research
associate professor of radiology, are coauthors of the
paper "Increased myocardial fatty acid metabolism in
patients with type 1 diabetes mellitus."
(Left) Janet McGill, MD.

But Gropler and his team believe
that, over a period of time, the
increased fat delivery will have
detrimental effects on the heart
muscle, reducing the glucose
uptake in the heart and affecting
processes related to cardiac
function as well as cell survival.
How long it takes for this kind
of effect to occur is unclear. "What
we can say, based on a few initial
studies, is that a person only has to
ingest fats and, thus, have high fat
delivery to the heart for just a few
weeks to see a reduction in its
energy production," says Gropler.
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The Metabolism of the
Diabetic Heart:

Not Just a Bystander in Heart Disease

Control-Palmitate

Diabetic-Palmitate

Fatty Acid Uptake:

Fatty Acid Uptake: 201 nmol/g/min

145 nmol/g/min

Fatty Acid Oxidation: 140 nmol/g/min

Fatty Acid Oxidation: 179 nmol/g/min

Myocordial images of C-l 1 palmitate uptake in a normal

in the blood and its delivery to the
heart. If so, lifestyle changes—such
as weight loss, exercise, and agents
to increase insulin resistance—
may be the answer.
To prove this hypothesis, the
group has currently undertaken a
comprehensive study involving
volunteers with type 2 diabetes,
who are screened to exclude those
with sub-clinical cardovascular disease and then randomly assigned to
several groups: one group will be
treated with conventional agents
to keep their blood sugar within
normal range, and other groups will
be treated with agents designed to
lower the fat delivery to the heart.
Confirmation of reduced fat delivery
to the heart will be achieved by
performing stable isotopic measurements of fat release by adipose
tissue—aided by nutrition expert

control and a diabetic patient. Highest uptake is white
and lowest uptake is black. C-l 1 palmitate uptake and,
thus, fatty acid uptake is higher in the diabetic patient.
Measurements of fatty add uptake and oxidation, as
measured by mathematical modeling of the PET data
demonstrate quantitatively higher fatty acid uptake and
oxidation in the diabetic heart.

A key clinical question is how
to prevent these cardiac consequences altogether—and that
question will guide the next phase
of the group's work. The working
hypothesis is that a major driver of
this problem is the level of insulin
resistance in diabetic patients:
Improving their insulin sensitivity
may reduce the fat release by adipose tissue, decreasing the fat level
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Samuel Klein, MD, of the
Department of Internal
Medicine. Combining
these measurements
with PET studies of
heart metabolism and
echocardiographic
studies of cardiac
function will permit a
comprehensive understanding of how
decreasing fat release
by the body's fat stores
may ultimately improve
cardiac metabolism and
function in patients
with diabetes.
"This study will
define for us whether,
in fact, fat delivery is
playing a role in cardiac
disease that afflicts diabetic
patients and why it is playing that
role," says Gropler. "The study also
will provide guidance as to whether
we should begin altering our therapeutic strategies to include paying
greater attention to the level of
fats in the blood and not just the
level of glucose."
At the same time, the Cardiovascular Imaging Laboratory is
looking at other related problems.
Do obesity and insulin resistance
contribute to these same alterations
in metabolism? What role does
aging or gender play in substrate
metabolism?
"We are excited about this
work," he says. "The beauty of
this technology and the strength
of these studies are that they
provide concrete information as
to what is happening in the
diabetic heart." EH
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Virtual
Colonoscopy
a Lifesaving Technology
by Anne Kessen Lowell

7B The dreaded colonoscopy has long been a staple of
the late-night comedy circuit—to wit the popular
lead-in, "I'd rather have a colonoscopy than...."
But the descent of popular culture into prurient and
scatological "humor"—via television, music, and Howard
Stern—has not led the American public to talk openly about
problems with, well, our bottoms. That, say health experts,
is keeping millions of Americans from getting the screening
test they need and putting them at risk for colon cancer.
Granted, a colonoscopy is not a walk in the park; it is a pain
the (you fill in the blanks). But the procedure has the power
to prevent the second most deadly cancer in the United States.
Health professionals and advocates are fighting to increase
awareness about colon cancer and the need for screening. And
clinical researchers are evaluating new noninvasive technologies
to make colon screening easier, faster, and more comfortable.

Virtual Colonoscopy:
a Lifesaving Technology

A\ I Mallinckrodl Institute
MM
of Radiology (MIR),
B ■
researchers are
^^^^^^^ some extraordinary
^7
^A volunteers in
promising study
involving computed tomography
(CT) colonoscopy, or "virtual"
colonoscopy. More than 150
volunteers to date have undergone
not one but two colon screening
procedures in one day. Christine
Menias, MD, assistant professor of
radiology at Washington University
in St. Louis School of Medicine and
a staff physician at Barnes-Jewish
Hospital, is leading the effort at
MIR, one of 15 sites across the
country involved in the National
CT Colonography Trial. The trial
is funded by the National Cancer
Institute (NCI) and coordinated by
the American College of Radiology
Imaging Network (ACRIN);
nationally 2,300 volunteers will
participate. CT colonography uses
noninvasive technology to look
inside the colon. The test can be
completed more quickly and
comfortably than optical
colonoscopy, the most effective
screening test in use today. The
purpose of the ACRIN trial is to
determine whether CT colonography is as effective as colonoscopy
in detecting polyps (the precursors
to cancer) and in detecting growths
that have already become cancers.
"We have to do everything
we can to increase preventive
screening," says Menias. "I see two
nonresectable colon cancer cases
every week at Barnes-Jewish
Hospital alone. This is simply
unacceptable. We must continue
to develop technologies that will
put patients at ease while providing
the same level of diagnostic accuracy we are accustomed to having."

V

Colon cancer is stealthy,
taking years to become a
threat. It can be prevented if
Stomach
polyps, the precursor to cancerous tumors, are found and
removed early. Polyps are
growths on the lining of the
colon that can mutate and grow
r*£
into a cancerous tumor mass.
Polyps are imperceptible without a view inside the colon;
they do not cause symptoms.
-Catord
By the time one notices blood
Smal
in the fecal stool or changes
Cecum | ,'
Intestine
in
bowel movements, or experiHeclum
Appendi:
ences pain, colon cancer may
Anushave spread outside the intestine
to other organs. At that point,
Use ofthifillustration from Wikipedia
the disease may be untreatable.
is grantaffi under the GNU Free
One of the biggest risk
Documentation License.
factors for colon cancer is age,
with 90 percent of cancers
appearing in people age 50 and
Colon Cancer Is
older. The disease hits the AfricanPreventable
American community especially
Cancers of the colon and
hard; the colon cancer death rate
rectum are ranked as the second
among African-Americans is 40
deadliest cancer, with more than
percent higher than for whites.
55,000 American deaths each year.
Inadequate screening may be a
(According to the Annual Report
primary reason for this disparity.
to the Nation on the Status of
Studies have estimated that only 30
Cancer, published in 2005 in the
percent to 50 percent of Americans
Journal of the National Cancer
over age 50—perhaps 42 million in
Institute, lung cancer is the leading
all—have been screened for colon
cause of deaths in men and
cancer. By comparison, 72 percent
women—more than 160,000 deaths
of women over age 50 have
annually.) About 147,000 Americans
received a mammogram, the
were diagnosed with colon cancer
screening test for breast cancer.
in 2005, and treatment costs in the
United States annually exceed
eight billion dollars. But colon
cancer (the term is commonly used
to include cancer of the colon and
rectum) also is the most preventable cancer. Controlling the
usual suspects—obesity, poor diet,
lack of exercise, and smoking—
can reduce individual risk, but
the most effective weapon against
colon cancer is early screening
and detection.
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A CT look inside the colon.
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Obstacles to Screening
Embarrassment and trepidation
contribute to low colon cancerscreening rates. "Paradoxically,
people don't get screened because
they think we'll find something.
And, let's face it, people don't like to
talk about colons," explains Menias.
But awareness and cost also
are culprits. Celebrity activism has
been effective in raising awareness,
notably by morning talk-show host
Katie Couric, who underwent a
colonoscopy before a national
television audience during a Today
Show segment in 2000. Former
major league baseball player Eric
Davis, a St. Louis Cardinal in the
1999-2000 season, overcame
colon cancer and is a determined
advocate for screening.

Lack of insurance coverage
prevents many people from being
screened. It was only in 2001 that
Medicare approved reimbursement
for screening colonoscopy for
people of "average" risk—that is,
beneficiaries age 50 and older.
Prior to that change, only fecal
occult blood tests (known as FOBT)
and sigmoidoscopy were covered,
with colonoscopy reserved for those
patients considered at high risk. In
many states, private insurance may
not cover the procedure. In 2006,
the National Colorectal Cancer
Research Alliance (known as
NCCRA and founded by Couric)
rated state-mandated private
insurance coverage for screening
colonoscopies. Missouri and
Illinois are among 14 states, along
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Common symptom
of colorectal cancer
• Change in bowel habits
• Diarrhea, constipation, or feeling
that the bowel does not empty
completely
• Blood (either bright red or very
dark) in the fecal stool

"There is not enough awareness\
...about the importance of screening,
especially for people at high risk."
Menias stresses that much
more should be done, especially in
the area of informing primary care
physicians. "There is not enough
awareness among primary care
physicians about the importance
of screening, especially for people
at high risk. It is a tragedy to see
patients in the emergency department with urgent symptoms
indicating colon cancer. We need
to give this disease the same priority
as other cancer screenings that
are now considered as routine."

colon cancer screening. [At press
time, according to the American
Cancer Society, a bill before the
United States Senate (Senate Bill
1955) may override state regulations and allow privateplrwi^to
exclude screening tests such as*
colonoscopies and mammograms.f

with the District of Columbia, that
received an "A" grade for basing
their coverage requirements on the
latest medical recommendations—
that is, for colonoscopy. A-rated
states go one step farther by referencing American Cancer Society
guidelines, allowing for coverage of
future advances in screening, such
as CT colonography. Twenty-eight
states were graded "F" by the
NCCRA, indicating they have no
legislation requiring any type of

• Fecal stools that are narrower
than usual
• General abdominal discomfort
(frequent gas pains, bloating,
fullness, and/or cramps)
• Weight loss with no known reason
• Constant fatigue
• Nausea and vomiting.
These symptoms are not unique
to colorectal cancer and may be
caused by other health issues.
If you experience any of the above
problems, contact your physician
for a proper diagnosis.
Information provided by the
National Cancer Institute.

Ruth Holdener (seated) and Christine Menias, MD,
review images obtained by a 64-detector CT scanner
that provides superior resolution and sharp images,
plus its surprising speed is a plus for patients.

"A colbnoscopy requires about
forty-five minutes for the procedure
and up to an hour for recovery,"
she notes. "Typically a sedative is
given, so the patient must have
someone drive them home, and the
patient likely will miss an entire
day of work. CT colonography is a
test with about five minutes of discomfort and a half hour of recovery. The patient couldfreturn to
work after the test."
The promise of CT colonography
to match or to better colonoscopy
as a diagnostic tool was first
demonstrated in 2003 by Perry
Pickhardt, MD, a 1999 graduate
of the MIR diagnostic radiology
residency training program and
now an associate professor in the
Department of Radiology at the
University of Wisconsin-Madison
Medical School. In a study of 1,233
asymptomatic adults, Pickhardt

atest with about five minutes of
discomfort and a half hour of recovery.
The patient could return to work
achieved polyp detection rates in
after the test."
Testing Day
Colonoscopy is the screening
tool most favored by physicians.
It has the highest accuracy rate in
detecting polyps and allows for the
removal of polyps during the procedure. But a colonoscopy can be
uncomfortable, may require hours
of recovery, and carries some risk.
Currently, technology cannot help
patients avoid the most unpleasant
part of either optical colonoscopy
or CT colonography: the "prep."
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For both tests the colon must be
vigorously cleansed: a feat accomplished by the patient consuming
up to one gallon of a laxative fluid
the night before the procedure.
Menias believes that the greater
convenience of CT colonography
on the day of the procedure will
convince more people to come in
for the screening test.

line with optical colonoscopy, even
in polyps as small as 6 millimeters
in diameter. Intrigued by these
results, NCI decided to support a
multicenter trial comparing the
two procedures.
Ruth Holdener is a research
assistant at MIR who is responsible
for recruiting volunteers for the CT
colonoscopy study. Holdener culls
the list of people scheduled for
colonoscopy for those eligible for
the trial. "Once I explain the objectives of the study, people are usually
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willing to volunteer. When the trial
first started, we ran one TV ad and
received about two hundred and
fifty telephone calls. We've already
exceeded our target enrollment
for the study."
In order to obtain comparative
data, each volunteer must undergo
both the CT colonography and
optical colonoscopy. Fortunately
only a single prep is required the
day before the procedures. For CT
colonography, patients also must
consume a small amount of barium
and another liquid called Gastroview®, which coats (or "tags") any
remaining fecal stool to distinguish
it on the CT image from polyps or
cancerous growths. No sedation is
given. As the patient lies on the
examination table, a small quantity
of carbon dioxide (C02) is introduced into the colon, scans are
taken in both the supine and prone
positions. "Most patients experience
about four to five minutes of discomfort," explains Menias. "The
carbon dioxide is absorbed or
expelled within half an hour."
After recovery from the
colonography, volunteers proceed
to the colonoscopy suite for the
second procedure. Later, they are
asked to compare their experience
with each test, to recount how
much time was required to recover

from the colonoscopy, and the time
spent by others to provide transportation and at-home care. The CT
colonography is provided free-ofcharge; the colonoscopy is charged
to the patient's insurance provider.

Future Advances
Menias looks forward to the
conclusion of the trial and the
release of the data. CT colonography
does have some advantages over
colonoscopy; it can measure polyps
with greater precision and allows
radiologists to quickly scan other
abdominal organs. So far in the
MIR trial, CT colonography has
detected kidney stones, gallstones,
and an adrenal cancer in volunteers.
"If we continue to perfect software technology and radiologist
training, CT colonography could
be an excellent complement to
colonoscopy," says Menias.
"Everyone could be screened when
they should be, faster and with less
discomfort. No one would have to
miss a day's work to get this important test. If polyps are detected in
CT colonography, the patient will
go straight to colonoscopy to have
the polyps removed. And one day
we may be testing a low-prep or noprep CT colonography, using
advanced fecal stool tagging
methodologies."

Resources
For information about MIR's
CT Colonography Trial, call
(314) 747-2034 or send an
e-mail to holdenerr@mir.wustl.edu.
Call St. Louis Connect Care at
(314) 879-6392 for information
about free fecal occult blood test
screening.
For colon and rectum cancer information online, visit these Web sites:
• American Cancer Society:
www.cancer.org
• National Colorectal Cancer
Research Alliance: www.nccra.org
• National Cancer Institute:
www.cancer.gov

Menias concedes this could be
years away and emphasizes that
raising awareness now is imperative. People at high risk for colon
cancer and those over age 50
should talk to their doctor now
about a screening test.
Everyone else should plan
to give themselves a lifesaver
for their fiftieth birthday: a colon
cancer-screening test. EM
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Embolization
An Alternative
to Hysterectomy
for Treating Fibroids
In the United States,
an estimated 5.5 million
women suffer with symptomatic
uterine fibroids. These are benign
tumors, or myomas, and can
cause significant problems that
may severely impact women's health.
by Mary Jo Blackwood, RJV, MPH, CHES

hey often compress the
bladder, causing urinary
frequency, urgency, and
m frei
incontinence. Or they
a inct
may create bowel problems
«^™» mav
or pain during intercourse. Over
eighty-five percent of the time,
symptoms include excessively
heavy, painful [menstrual] periods;
some patients can become severely
anemic. Symptomatic fibroids can
range in size from several millimeters to larger than [the equivalent
of] a pregnancy," says David
Hovsepian, MD, an interventional
radiologist with Mallinckrodt
Institute of Radiology and a staff
physician at Barnes-Jewish Hospital.
Fibroids usually will shrink on
their own once menopause has
begun, because of the decrease in
circulating estrogen. But many
women experience symptoms
long before that point. Treatment
options include hormonal therapies
or surgery, either myomectomy
(excision of individual fibroids)
or, more commonly, hysterectomy
(surgical removal of the entire
uterus). An option preferred by
many women is one of Hovsepian's
specialties—uterine fibroid
embolization (UFE).

How UFE Works
UFE (sometimes referred to
as uterine artery embolization or
UAE) takes about an hour and only
requires intravenous sedation and
local anesthesia. Similar to a heart
catheterization, a small plastic tube
(catheter) is inserted first into the
femoral artery in the groin, which
is then threaded into the uterine
arteries where tiny embolic particles—about the size of grains of
sand—are released. Propelled by
blood flow, the particles become
lodged in the tiny branches that
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(Left) Pre-UFE: Here, the fibroids fill the uterus. The catheter is seen an the left.
(Right) Post-UFE: The fibroids have diminished because their blood supply was blocked by the embolic particles fed
through the catheter.

feed the uterus and fibroids and
block their blood supply. The
uterus is able to draw on other
vessels to sustain itself and is
totally recovered within a few
days. Fibroids have no such
capacity and quickly starve to
death. On average, fibroids will
shrink to 50 percent or 60 percent
of their volume and become soft
and spongy, relieving pressure on
adjacent organs.
Interestingly, says Hovsepian,
UFE as a primary treatment for
fibroids was discovered by accident in France in the early 1990s.
A severe nationwide blood supply
shortage prompted surgeons to
request that a patient have uterine
embolization a few weeks before
myomectomy to help reduce blood
loss during what can be very
bloody surgery. A significant
number of those women who had
undergone embolization later
refused myomectomy because
their symptoms were improving.

Before the '90s, UFE commonly
was performed by interventional
radiologists for postpartum hemorrhage and for pelvic trauma—its
use as an adjunct or stand-alone
treatment for uterine fibroids has
been adopted rapidly, and the
number of procedures performed
worldwide probably tops 100,000.
"The symptoms, such as excessive bleeding or pelvic pressure,
are permanently relieved approximately eighty-five percent of the
time. Shrinkage is often modest,
and softening probably accounts
for a lot of the improvement in
symptoms. So if a woman expects
her stomach to be flat when the
procedure is done, she will be
disappointed," says Hovsepian.
"Our goal is to treat symptoms.
This is not a cosmetic procedure.
UFE generally turns the clock back
about five years for women with
fibroids and returns them to a point
where they had not yet begun
to experience symptoms."
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David Hovsepian, MD. In the background are monitors connected to a digital fluoroscopy unit, which displays
the UFE procedure in real time.

The most common symptoms
following UFE are cramps and
fatigue. For that reason, Hovsepian
admits his patients to the hospital
overnight after UFE to optimize
their comfort. "Some centers allow
patients to go home the same day,
but recovery can sometimes be
more than oral medications can
handle. A significant percentage of
women, perhaps as high as fifteen
percent, will return to the hospital
because of inadequate pain control.
That is unacceptably high for me,"
says Hovsepian.
Following UFE, cramping is
usually intense for four hours to six
hours, tapering off over the next
day or so. Patients may take painrelief medication for a few days
and are given an anti-inflammatory
medication for a week. Most
women recuperate within a few
days but often are surprised by the
degree of fatigue as the body
musters resources to heal itself.
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According to Hovsepian, "Some
women go back to work within a
week but find they 'run out of
steam' by late afternoon for a few
days longer. I encourage them to
try to take two weeks off from
work, with the option of working
from home or returning part time
during the second week, if they
feel it's necessary."

Diagnosis and
Treatment Planning
Hovsepian, an associate professor of radiology at Washington
University in St. Louis School of
Medicine, believes the most effective
diagnostic tool available for differential diagnosis of fibroid symptoms
is pelvic magnetic resonance imaging
(MRI). "Most gynecologists are
extremely comfortable with using
US [ultrasound] and often have US
labs in their offices. It has been
difficult to convince them that the

diagnostic information provided by
MRI justifies the cost. My experience, and that of other physicians,
is that the results of a pelvic MRI
change the treatment plan about
fifteen percent of the time," he
says. Hovsepian notes that MRI
effectively has replaced the need
for a physical examination and shows
not only the uterus and its internal
architecture but all of the other
pelvic organs to best advantage.
"MRI can demonstrate uterine
anomalies and conditions such as
endometriosis and often displays
the ovaries when an ultrasound
was unable to distinguish them.
MRI often shows many more
fibroids than the US exam revealed
and allows the physician to correlate symptoms better because the
location, with respect to the uterus
and adjacent organs, is clearly
visible," says Hovsepian. "Fibroids
don't have to be very large to cause
severe bleeding if they arise just
beneath the endometrial lining.
There also are mimickers of
fibroids that can be discerned
by MRI, such as adenomyosis
[endometriosis within the uterine
wall] that can cause menstrual
pain and heavy bleeding."
After a patient has had a pelvic
MRI and has been determined to be
a candidate for UFE, she and her
husband or partner are encouraged
to come in for consultation. The
clinic visit includes an informational
video and a question-and-answer
segment. Hovsepian then meets
with each couple individually
to review the MRI scan, answer
more personal questions, and
address issues relevant to each
patient's situation.
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(Top) MRI scan of uterine tumor taken prior to UFE.
(Bottom) MRI scan taken after UFE.

"Before we started doing
the group seminars, consultations
were taking longer and longer—
sometimes hours—and I was
largely repeating myself. The video
allows me to cover a lot of information without accidentally leaving
things out," he says. "The time I then
spend with patients, both in the
group Q-and-A session and individually, is put to much better use.
Many of the attendees already have
been using the Internet, 'Googled'
me, and come in with a list of questions. Now I can usually make sure
all of their questions are answered."

Track Record
Gynecologists perform approximately 250,000 surgeries for
fibroids each year nationwide.
According to a Wall Street Journal
article (August 24, 2004), most
women with symptomatic fibroids
are not informed by their gynecologists that UFE is an option. The
article postulated why this alterna. tive to hysterectomy often goes
unmentioned—namely, money.
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Gynecologists have not
been trained to perform
UFE, which is being performed and promoted by
interventional radiologists, so
the potential loss in income
for gynecologists has been
estimated to be as high as
$400 million.
The article went on to
note that some gynecologists
view UFE as an experimental
procedure, although this
view is changing. However,
many women still have to
mention UFE when discussing
fibroid treatment options with their
gynecologist, and many patients
going in for an office visit are better
informed about UFE than are
their doctors—thanks in part to
the Internet.
Hovsepian is happy to hear
that UFE is increasingly mentioned
as an alternative but is disappointed
at how often misinformation
is passed along to patients. "Many
times, women might have been
informed about UFE but were
quickly told that it was not
an option for them because there
were too many fibroids or the
fibroids were too large—when
that was not the case at all. I am
always grateful when I hear a
woman say that her doctor told her
that he didn't know much about
the procedure and to contact us to
learn more about it," he says. "At
the Washington University Comprehensive Fibroid Center, we have
treated approximately four hundred
women since we started doing
UFE in 1998. Fortunately, UFE has
become widely accepted by insurance carriers and health plans,
including Medicare and Medicaid."

Facts & Figures
• An estimated 40 percent of all women
have uterine fibroids. While most women
have no symptoms, one in four eventually
has symptoms severe enough to require
treatment.
• African-American women are two times to
three times more likely to have symptomatic
uterine fibroids, typically at a younger age
than the rest of the population of women
with uterine fibroids.
• Asian women have a lower incidence of
symptomatic uterine fibroids.
• Average age range in which fibroids
become symptomatic is 35 years to 50
years.
• Obesity is associated with the presence of
uterine fibroids.
• High consumption of red meat and ham
has been associated with the presence of
uterine fibroids.
• Research has shown some reduced incidence of uterine fibroids in women whose
diet was high in green vegetables, fruit,

and fish.
• Changes in a woman's hormone levels
may impact fibroid growth.
• Fibroids grow rapidly during pregnancy
when hormone levels are elevated and
tend to shrink after menopause when
hormone levels are decreased.
Information excerpted from the National
Uterine Fibroids Foundation Web site at
www. nuff. org/health .htm.

Pricewise, though, UFE has
no advantage over hysterectomy
or myomectomy, he adds. "The real
savings come after the procedure.
Patients recover quickly and return
to work earlier, and there is no incision to heal. Patients' quality of life
is improved because they are back
to their usual activities sooner. That's
a savings for employers, patients,
and insurers," says Hovsepian.
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A female flight attendant cited
in the Wall Street Journal article
was recommended to have a hysterectomy for her fibroids but then
found out about UFE and had it
performed. She was back at work
in a week, as compared to the usual
four weeks to eight weeks she would
have been off the job after surgery.
National statistics show that
10 percent to 15 percent of women
who have UFE will need a foUow-up
procedure, usually some years
later, because of recurrent symptoms from fibroids that either did
not fully succumb or from growth
of new fibroids. "UFE kills the
majority of existing fibroids,
but these women have already
demonstrated that their uterus has
a propensity to make fibroids. A
significant number of women we
have treated with UFE already have
had one or more myomectomies in
the past," explains Hovsepian.
According to Hovsepian,
myomectomy is still considered the
treatment of choice for women who
want to conceive; although, if there
are too many fibroids or if the fibroids
are too large, myomectomy surgery
can be challenging and a hysterectomy may be necessary because the
surgical defects are too extensive to
close. "For those women, UFE may
Hovsepian and his interventional radiology
colleagues perform a variety of inpatient
and outpatient procedures for
gynecological patients:
• Fallopian tube recanalization
for infertility
• Treatment of pelvic venous congestion
syndrome
• Vascular access for chemotherapy
and/or nutrition
• Gastrostomy tube placement for nutrition
or decompression
• Abscess drainage
Vena cava filter placement.
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"The procedure was so comfortable, it was almost a nonevent.
That certainly wouldn't have been true of the hysterectomy my doctor
wanted me to have." Linda Whiteside is talking about uterine fibroid
ernbolization [UFE], a procedure she underwent to treat symptoms from
large uterine fibroids. She was having painful, heavy-flow menstrual
periods that caused anemia, and she
experienced urinary urgency from the fibroids
pressing on her bladder.
"My doctor didn't give me a choice of
not having a body part removed. I was
afraid of the shock on my body that sudden
menopause would cause and the length of
time I would have to be off work, so I
researched other options and came up with
UFE. I had a pelvic MRI done and then sat
down with my husband and Doctor Hovsepian to go over the results. He [Hovsepian]
showed me the fibroids [on the MRI] and
where they were exerting pressure. He even
Linda Whiteside
pointed out a bulging disc in my spine. It
was very interesting and comforting. I really understood what I could
gain by having this procedure," she says.
More importantly, the procedure accomplished what she had hoped
it would. Her urinary symptoms were alleviated almost immediately, and
her next menstrual period was much lighter. She received intravenous
sedation and was connected to a "pain pump" before the procedure
began. Whiteside experienced only some mild cramping and nausea
afterwards. She was in the procedure room for less than an hour and
went home after one night in the hospital. She was back at work as a
hairdresser one week later.
"When I told other women about this procedure, several said that
if they had known about it, they would never have had a hysterectomy.
Condoleezza Rice [United States Secretary of State] even chose UFE as
treatment for her fibroids, so I'm in good company," says Whiteside.

be a reasonable alternative, but
there are no studies to date that
prospectively have evaluated the
issue of fertility after UFE. There
have been reports of normal pregnancies and vaginal deliveries, but
it is too early to say whether UFE
will be an appropriate choice
for women desiring to preserve
fertility," he says.

Referrals
Fortunately, enlightenment
about UFE seems to be building.
Across the country, more and more
gynecologists are proponents of
ernbolization because it is, in their
opinion, an excellent treatment
option for the all-too-common

uterine fibroid problem. Hovsepian
gets most of his referrals from
gynecologists in the St. Louis area,
and the Washington University
Comprehensive Fibroid Center has
the largest experience with UFE in
the region. Approximately ten percent of Hovsepian's patients are
self-referred and learned about the
procedure from family, friends,
media, or the Internet. EHH
Editor's note: To speak to a doctor or
nurse about UFE, call (314)362-2375
or toll-free at 1-866-254-7237. For
more information about UFE and the
Washington University Comprehensive
Fibroid Center, go online at
www.mir.wustl.edu/patient/
internal.asp?NavID=563.
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FYI
In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the
'Department of Radiology are highlighted in boldface type.

[EW FACULTY
James Quirk, PhD, research
instructor in radiology, Division
[of Radiological Sciences.
iRajendra Singh, PhD,
research instructor in radiolI ogy, Division of Radiological
I Sciences.

Yuan-Chuan Tai, PhD,
assistant professor of radiology, as principal investigator,
received a two-year grant
from The Susan G. Komen
Breast Cancer Foundation
for "Feasibility study of a
high-resolution breast coil
for PET-CT scanners." Coinvestigator for the $249,349
grant is Joseph O'Sullivan,
PhD, professor of electrical
and systems engineering
and of radiology

RANTS
Jennifer
Gould, MD, assisJer
tant professor of radiology,
received a three-year grant
from the Society of Interventional Radiology Clinical
Fellowship Research Training
Program. The $30,000 grant
will fund projects conducted
by Mallinckrodt Institute interventional radiology fellows.
Vamsidhar Narra, MD,
associate
a;
professor of radioligy, received a six-month
grant in the amount of
$30,000
from the Barnes$;
T,
Jewish
Hospital Auxiliary for
research on "Body MRI for
quicker evaluation of cancer
response to chemotherapy."
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APPOINTMENTS/
ELECTIONS
Maurizio Corbetta, MD,
professor of neurology, of
radiology, and of anatomy
and neurobiology, was
appointed chairman of the
Program Committee for the
12th Annual Meeting of the
Organization for Human
Brain Mapping, Florence,
Italy, June 11-15.
Michael Darcy, MD, professor
of radiology, was elected to
a two-year term as vice
chairman of the Society of
Interventional Radiology
Foundation. He will become
chairman of the Foundation
in 2008.

Colin Derdeyn, MD, associate professor of radiology,
was elected chairman of the
National Institutes of Health
Data Safety and Monitoring
Board for the National Institute of Neurological Disorders
and Stroke projects—
P50NS044378 "MR and
Mechanical Revascularization
of Stroke Clots Using
Embolectomy (MR Rescue),
and P50NS044148 "Intravascular Cooling in the Treatment
of Stroke-Longer tPA Window
(ICTuS-L)." He also was
appointed to the Program
Committee for the 31st Annual
International Stroke Conference, Kissimmee, Florida,
February 16-18.
Igor Efimov, PhD, associate professor of biomedical
engineering and of radiology,
was elected chairman of the
Cardiac Arrhythmia Mechanisms Gordon Research
Conference to be held in
Ventura Beach, California,
March 18-23, 2007. He also
was elected to the editorial
boards of the scientific
publications Circulation
Research, Heart Rhythm,
Journal of Cardiovascular
Electrophysiology, Journal
of Molecular and Cellular
Cardiology, and Experimental
Physiology.
Jay Heiken, MD, professor
of radiology, was appointed
to a four-year term (2005-2009)
on the Board of Trustees of
the International Cancer
Imaging Society and to a sixyear term (2006-2012) on the
Board of Directors of the
Society of Gastrointestinal
Radiologists.

Fred Prior, PhD, research
associate professor of radiology, was appointed to the
National Alliance for Medical
Image Computing Advisory
Board.
Douglas Rowland, PhD,
research instructor of radiology, was elected to a second
term as treasurer of the
National Postdoctoral
Association.
Sally Schwarz, RPh, MS,
research associate professor
of radiology, was elected to
a three-year term as a member
of the Certification Board of
Nuclear Cardiology.
Yuan-Chuan Tai, PhD,
assistant professor of radiology,
was elected to a two-year
term as a member of the
Nuclear and Imaging Sciences
Council of the Institute of
Electrical and Electronic
Engineers Nuclear and
Plasma Sciences Society.
Franz Wippold, MD, professor of radiology, was
appointed to a one-year term
as a member of the American
College of Radiology Appropriateness Criteria Committee.
Pamela Woodard, MD, associate professor of radiology,
was appointed to a two-year
term as a member of the
American Heart Association
Program Committee for
Annual Scientific Sessions.
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HONORS/AWARDS
Carolyn Anderson, PhD,
associate professor of radiology and of molecular biology
and pharmacology, organized
Frontiers in Biological Imaging: From Cells to Humans at
the annual meeting of the
American Association for
the Advancement of Science,
St. Louis, Missouri, February
16-20.
Louis Gilula, MD, professor
of radiology and of surgery,
and coauthor Douglas Smith,
MD, South Texas Radiology
Group, San Antonio, received
the award for Best Paper
Presentation—Interventional
Spine for "A previously
unreported and novel
approach to sacroplasty"
at the American Society of
Spine Radiology 2006 Annual
Symposium, Las Vegas,
Nevada, February 22-26.

Robert Gropler, MD,
professor of radiology, of
medicine, and of biomedical
engineering, served as course
chairman of Images to Outcomes VI: Cardiovascular
Imaging, Nuclear Cardiology,
and Beyond, presented by
the Division of Nuclear
Medicine at Mallinckrodt
Institute of Radiology and
the Cardiovascular Division of
the Department of Medicine,
St. Louis, Missouri, April 28
and 29.
Fred Prior, PhD, research
associate professor of
radiology, served as session
chairman and program committee member for the Open
Source Strategy for MultiCenter Image Management
Conference, Las Vegas,
Nevada, March 6-9.

Biello Lecture
On March 8, David Mankoff, MD,
associate professor of radiology,
University of Washington, Seattle,
presented the Twentieth Annual
Daniel R. Biello Memorial Lecture.
He spoke on "Molecular imaging to
direct cancer therapy: from early drag
trials to clinical practice."

Marcus Raichle, MD,
professor of radiology, of
neurobiology, and of neurology,
served as a moderator for
Frontiers in Biological Imaging: From Cells to Humans at
the annual meeting of the
American Association for the
Advancement of Science,
St. Louis, Missouri, February
16-20.
Lawrence Tarbox, PhD,
research assistant professor
of radiology, served as a
session panelist for the Open
Source Strategy for MultiCenter Image Management
Conference, Las Vegas,
Nevada, March 6-9.

LECTURES
Carolyn Anderson, PhD,
associate professor of radiology and of molecular biology
and pharmacology, presented ' I
"Education in imaging
sciences: the next frontier,"
at the American Association
for the Advancement of Science annual meeting, St. Louis,
Missouri, February 16-20.
Jeffrey Brown, MD, professor
of radiology, spoke on "MRI
of cholangiocarcinoma and
gallbladder cancer"; "MRI of
the indeterminate renal
mass"; "Body MRI: Should it
replace CT?"; and "Successful
investment strategies for
physicians" at the Los Angeles |
Radiology Society 58th
Annual Mid Winter Conference, Los Angeles, California, !
January 28 and 29.
Maurizio Corbetta, MD,
professor of neurology, of
radiology, and of anatomy
and neurobiology, presented
"Prospective of physician
scientists in the 21st century" |
at the Winship Cancer
Institute, Emory University,
Atlanta, Georgia, April 22.
Colin Derdeyn, MD, associ
ate professor of radiology, of .
neurology, and of neurologic al ,
surgery, spoke on "Acute
stroke intervention" at
Medical Grand Rounds,
St. Joseph's Hospital,
St. Charles, Missouri,
February 7. He presented
"Evidence based management
of raptured intracranial
aneurysms" at the 31st
Annual International Strok
Conference, Kissimmee,
Florida, February 16-18.
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i He spoke on "Diagnosis of
I vasospasm" at the 9th Annual
Joint Meeting of the American
; Association of Neurological
Surgeons/Congress of Neurological Surgeons Joint Section
on Cerebrovascular Disease
jid American Society of
nterventional and Therapeutic
vfeuroradiology, Orlando,
Florida, February 17-20.

"Structure/function of the
supraventricular pacemaking
and conduction system of the
rabbit heart" at Experimental
Biology 2006: Advancing the
Biomedical Frontier, sponsored by the Federation of
American Societies for
Experimental Biology,
San Francisco, California,
April 1-5.

Igor Efimov, PhD, associate
professor of biomedical engineering and of radiology, as
le Doris J. W. Escher,
M.D. Lecturer, presented
"History and mechanisms of
defibrillation: toward painless
defibrillation" at Cardiology
Grand Rounds, Albert Einstein College of Medicine,
Montefiore Medical Center,
[ New York City, New York,
February 14. He presented
"Imaging cardiac arrhythmias" to the Department of
Biomedical Engineering,
Saint Louis University,
St. Louis, Missouri, February
18. As the Astor Visiting
Fellow, Efimov spoke on
"Structure/function relationship of the pacemaking and
conduction system of the
! heart," "Towards painless
defibrillation: virtual electrode
theory of electrical stimulation
of the heart," and "Imaging
arrhythmias in 3D: the final
frontier" at the University
of Oxford, Oxford, England,
March 13-17. He spoke on

Dione Farria, MD, associate
professor of radiology, as
keynote speaker, presented
"Disparities in breast cancer
screening and diagnosis" at
2006: Genomics of Health
Disparities Symposium,
sponsored by the Federation
of American Societies for
Experimental Biology, San
Francisco, California, April 1-5.
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David Gierada, MD, associate professor of radiology,
spoke on "CT evaluation of
the chest wall" and "Lung
cancer screening: pros and
cons" at the Medical College
of Wisconsin, Milwaukee,
March 6.
Louis Gilula, MD, professor
of radiology and of surgery,
spoke on "Longitudinal
approach to sacroplasty" at
the American Society of
Spine Radiology 2006 Annual
Symposium, Las Vegas,
Nevada, February 22-26.
As visiting professor, he
presented "Musculoskeletal
board review" at Oregon
Health and Science University,
Portland, April 10 and 14.

Perry Grigsby, MD, professor of radiation oncology and
of radiology, presented
"Clinical and translational
science for FDG-PET in
cervix cancer" at Grand
Rounds, Rambam Medical
Center, Haifa, Israel, January
9. He presented "Brachytherapy for cervical cancer"
and "Current radiotherapy
approach to pelvic malignancies" to the Israeli Society
for Clinical Oncology and
Radiation Therapy, Eilat,
Israel, January 11-14.
Grigsby spoke on "Technique
and results of HDR intracavitary brachytherapy for cervical
cancer" at the 16th Annual
Meeting of the Association
of Clinical Research organizations, Orlando, Florida,
February 23-25. He spoke
on "Cervix cancer" at
the American Society for
Therapeutic Radiology and
Oncology Spring Refresher
Course, Miami, Florida,
March 24-26. He presented
"Radiotherapy vs.
chemotherapy in advanced
staged endometrial cancer,"
"Role of radiotherapy in
surgically staged endometrial
cancer," and "Adjuvant radiotherapy in cervical cancer" at
the 10th Biannual Congress
of Turkish Gynecological
Oncology Society, Antalya,
Turkey, April 18-23.

Robert Gropler, MD,
professor of radiology, of
medicine, and of biomedical
engineering, spoke on
"SPECT evaluation postrevascularization," "SPECT
evaluation in heart failure,"
and "Read with the experts:
SPECT and SPECT/CT" at
Images to Outcomes VI:
Cardiovascular Imaging,
Nuclear Cardiology, and
Beyond, presented by the
Division of Nuclear Medicine
at Mallinckrodt Institute
of Radiology and the Cardiovascular Division of the
Department of Medicine,
St. Louis, Missouri,
April 28 and 29.
Jay Heiken, MD, professor
of radiology, presented
"Virtual colonoscopy: update
2006," "Acute small bowel
obstruction: CT evaluation,"
"Principles of contrast
administration and scan
timing for MDCT," and
"Abdominal aorta: aneurysm
rupture and post-operative
complications" at Radiology
at the Seashore: A Practical
Approach, sponsored by the
University of Michigan Medical School, Naples, Florida,
February 6-10. He presented
"Optimizing contrast
enhancement for MDCT" and
participated in the Special
Focus Session: MDCT in
Theory and Practice at the
European Congress of Radiology, Vienna, Austria, March
3-7. He spoke on "Emergency
radiology of the abdomen"
at the 38th International
Diagnostic Course in Davos:
Diseases of the Abdomen and
Pelvis, Davos, Switzerland,
April 1-7.
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LECTURES
Continued from page 25
Linda Larson-Prior, PhD,
research associate professor
of radiology, spoke on
"Imaging neural function
across scale: the promise of
multi-modal imaging" in the
Center for Neurodynamics,
Department of Physics and
Astronomy, University of
Missouri—St. Louis, March 24.
Jason Lewis, PhD, assistant professor of radiology,
presented "Imaging tumor
hypoxia: the translation of
Cu-ATSM from the bench to
the clinic" at St. Thomas
Hospital, London, England,
May 22. He spoke on
"Metal-based PET radiopharmaceuticals: from pre-clinical
development to clinical
application" at Oxford
University, Oxford, England,
May 23.
Vamsidhar Narra, MD,
associate professor of radiology,
spoke on "Contrast enhanced
MRA of the abdominal aorta
and the renal arteries," "Contrast enhanced MRA run-off,"
and "MRCP: techniques and
clinical applications" and
presented a workstation
demonstration at the 6th
Annual Snowmass 2006:
New Advances in MR and
CT, Snowmass Village,
Colorado, February 19-24.
Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, spoke on "Population
studies of dystonia" at Genetic
Advances in Dystonia Workshop, sponsored by the
Dystonia Medical Research
Foundation, Phoenix,
Arizona, January 30. He
presented "Neuroimaging
biomarkers of P.D. progression" at the World Parkinson
Congress, Washington, DC,
February 22-26.

Fred Prior, PhD, research
associate professor of
radiology, presented "Image
management for research
and clinical trials" at the
Open Source Strategy for
Multi-Center Image Management Conference, Las Vegas,
Nevada, March 6-9. He spoke
on "Current status: CAB16
imaging software" at the
Cancer Bioinformatics Grid
annual meeting, Washington,
DC, April 9-11.
Marcus Raichle, MD,
professor of radiology, of
neurobiology, and of neurology,
presented the George C.
Cotzias Lecture—"The
visible brain: an evolving
perspective"—at the 58th
Annual Meeting of the American Academy of Neurology,
San Diego, California, April 1-8.
Stuart Sagel, MD, professor
of radiology, as visiting professor, presented "Interactive
case discussions" to the
Department of Radiology,
University of Arizona,
Tucson, March 30.

Gordon Shulman, PhD,
research associate professor
of neurology and of radiology,
presented "Brain systems for
voluntary control of human
spatial attention" to the
Department of Psychology,
University of Missouri—
Columbia, March 10.
Barry Siegel, MD, professor
of radiology and of medicine,
presented "The female genitourinary tract," "PET/CT of
the breast," "Evaluation of
melanoma," "The National
Oncologic PET Registry,"
and "Monitoring and predicting response to therapy in
oncology" at Nuclear Medicine
2006: PET and PET/CT
Imaging, Palm Beach, Aruba,
January 22-26. He spoke on
"PET and PET/CT artifacts
and variants," "PET/CT in
lung cancer," and "PET/CT
in women's cancer" and

participated in Interesting
Cases: Read with the Experts
at The Next Step in Molecular
Imaging—PET/CT Scanner,
sponsored by the Positron
Emission Tomography
Center, St. Luke's Medical
Center, Quezon City, Phillippines, March 3. As visiting
professor, Siegel spoke on
"PET and PET/CT in
women's cancers" at Robert
Wood Johnson Hospital,
University of Medicine and
Dentistry of New Jersey,
New Brunswick, March 16.
He spoke on "Applications of
PET and PET/CT in clinical
oncology" and "PET and
PET/CT in women's cancers"
at Allegheny General Hospital,
Pittsburgh, Pennsylvania,
March 20. He presented
"Clinical applications of PET
for cancer diagnosis and
staging," "PET in oncology:
monitoring and predicting

Senturia Lecture
Cheryl Petersilge, MD, assistant
clinical professor of radiology and
orthopedic surgery at Case Western
Reserve University, Cleveland, Ohio,
presented the Twelfth Annual
Hyman R. Senturia Lecture on
February 6. She spoke on "Imaging
of the painful hip and pelvis."

La
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response to therapy," "PET
breast cancer," and "PET
oncology: beyond FDG"
it the 26th Annual Course
Computed Tomography,
Magnetic Resonance Imaging
I and Positron Emission
I Tomography, Auchterarder,
■ I Scotland, April 9-13. As the
I Wendell Scott Lecturer,
•■ Siegel spoke on "Positron
emission tomography in
_ breast cancer" at the 32nd
i National Conference on
t Breast Cancer, sponsored by
: the American College of
of ] Radiology, San Diego,
1 California, April 28-30.
Marilyn Siegel, MD, profesI sor of radiology and of
pediatrics, spoke on
"Imaging the child with acute
abdominal pain" and
ST
f "Congenital abnormalities"
I and presented "Advances in
congenital heart disease
imaging" at a Special Focus
Session at St. Luke's Medical
Center, Quezon City, Phillipines, March 3. She spoke on
I "Pediatric pelvic masses,"
"Pediatric hepatic lesions," and
I "CT of vascular mediastinal
abnormalities" at the 26th
Annual Course in Computed
Tomography, Magnetic Resonance Imaging and Positron
Emission Tomography,
Auchterarder, Scotland,
April 9-13.
Lawrence Tarbox, PhD,
research assistant professor
of radiology, spoke on
"Application hosting: a standardized API for launching
and communicating with
'plug-in' applications" at the
Open Source Strategy for
Multi-Center Image Management Conference, Las Vegas,
I Nevada, March 6-9. He
presented "Using MIRC to

'j
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access research images in
a HIPAA world" at Imaging
Informatics in Focus, the
2006 Annual Meeting of the
Society for Computer Applications in Radiology, Austin,
Texas, April 27-30.
Franz Wippold, MD, professor of radiology, presented
"Imaging and the law: judging
the book by its cover" at the
United States Attorney's
Office of the Eastern District
Legal Seminar, St. Louis, Missouri, February 16. He spoke
on "Imaging the degenerative
lumbar spine" at the annual
meeting of the American
Academy of Orthopedic
Surgeons, Chicago, Illinois,
March 24.
Pamela Woodard, MD,
associate professor of
radiology, as visiting professor,
presented "Delayed contrastenhanced cardiac MR" and
"Coronary CT angiography"
at the University of Indiana
Medical Center, Indianapolis,
March 1 and 2. She spoke on
"Evaluation of pulmonary
arterial hypertension and
right ventricular function
with MR" at the Society of
Thoracic Radiology annual
meeting, Orlando, Florida,
March 14. She spoke on
"Read with the experts:
CT" at Images to Outcomes
VI: Cardiovascular Imaging,
Nuclear Cardiology, and
Beyond, presented by the
Division of Nuclear- Medicine
at Mallinckrodt Institute
of Radiology and the
Cardiovascular Division of
the Department of Medicine,
St. Louis, Missouri,
April 28 and 29.

SYMPOSIA
In this section ofFYI, only
those faculty and staff who
have Department of Radiology appointments are listed.

SOCIETY OF GASTROINTESTINAL RADIOLOGISTS
AND
SOCIETY OF UR0RADI0L0GY
Abdominal Radiology
Course 2006
Kauai, Hawaii
February 26—March 3, 2006
WORKSHOPS
Dennis Balfe, MD,
"American Board of
Radiology: update 2006."
Jay Heiken, MD, "Cystic
neoplasms of the pancreas."
Christine Menias, MD,
"CT of the right lower
quadrant pain."
Sharlene Teefey, MD,
"Duplex color Doppler
of liver."
MULTIDETECTOR CT
Jay Heiken, MD, "Radiation
and contrast issues for
MDCT."
ABDOMINAL MULTIDETECTOR CT
Dennis Balfe, MD, moderator
SELF ASSESSMENT MODULE (SAM)
Dennis Balfe, MD, "Liver—
focal benign lesions; focal
malignant lesions; diffuse
liver disease."

PLENARY SESSIONS
Gynecological and Breast Cancers
Farrokh Dehdashti, MD,
"PET/CT in ovarian and uterine cancer."
Perry Grigsby, MD, "PET
imaging of cervical cancer."
Role of Imaging in Diabetes

Robert Gropler, MD,
"Imaging of substrate
metabolism in diabetes."
Radiotracer Imaging in
Heart Failure—The Role
of Molecular Imaging
Robert Gropler, MD,
"Imaging metabolism in
heart failure."

SOCIETY OF INTERVENTIONAL RADIOLOGY
31st Annual
Scientific Meeting
Toronto, Ontario
March 30—April 4, 2006
CATEGORICAL COURSES
Daniel Brown, MD,
panelist, Case Based Review:
Non-vascular Interventions.
Michael Darcy, MD,
moderator, GI Bleeding;
panelist, Case Based Review:
Non-vascular Intervention;
"Introduction to course and
MOC self assessment";
"Pre-procedure clinical
assessment and management";
"Update on results for bleeding and ascetic indications."
Jennifer Gould, MD, "Management of lower GI bleeding."

ACADEMY OF MOLECULAR
IMAGING
Annual Conference
Orlando, Florida
March 25-29, 2006
Barry Siegel, MD, "An
overview of the National
Oncologic PET Registry."
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PLENARY SESSIONS
Daniel Brown, MD, "Ablation of hepatic malignancy:
When are we helping the
patient and when are we
kidding ourselves?"
Suresh Vedantham, MD,
moderator, Venous Thromboembolic disease: Big
Problem, No Easy Answers;
"Lower extremity DVT: When
is intervention indicated?'

WORKSHOPS
Daniel Brown, MD, coordinator, Gastrointestinal IR:
Techniques and Management.
Suresh Vedantham, MD,
coordinator, Thrombolytic
Therapy for Venous Thrombolysis Disease.

SOCIETY OF COMPUTED
BODY TOMOGRAPHY AND
MAGNETIC RESONANCE

Dennis Balfe, MD, "MDCT
for diagnosing ischemia
of the small bowel and
mesentery."
Marilyn Siegel, MD,
"MDCT in children:
techniques, applications and
risks"; "CT/MR of pediatric
mediastinal masses."

GENITOURINARY IMAGING
Dennis Balfe, MD, "Imaging of the subperitoneum:
What is it and why is it
important?"

THORACIC IMAGING
Stuart Sagel, MD,
moderator, Thoracic Imaging—Session II; "Lung cancer screening: status in
2006"; "CT of the pleura";
"Interactive case review:
chest."

IMAGING SCIENCES
RETREAT
St. Louis, Missouri
April 21 and 22, 2006

EDUCATION IN
IMAGING SCIENCES

29th Annual Course
Phoenix, Arizona
April 3-7, 2006

Carolyn Anderson, PhD,
"Graduate education in
imaging sciences at WU."

GASTROINTESTINAL IMAGING

STATE-OF-THE-ART IN
BIOMEDICAL IMAGING AT
WASHINGTON UNIVERSITY

Kyongtae Bae, MD, PhD,
"PET/CT of the abdomen
and pelvis: strengths and
weaknesses from a body
imager's perspective"; "Principles and practice of contrast material delivery in
MDCT"; "Interactive case
review: GI."

Joseph Ackerman, PhD;
Robert Gropler, MD,
moderators.
Gilbert Jost, MD, introduction, keynote presentation.

Editor's Note: An abstract presented at the Society
for Molecular Imaging (listed on page 31 in the
Winter 2005/2006 issue of Focal Spot) should
have read as follows: Scott Harpstrite; Julie Prior;
Jiling Song; David Piwnica-Worms, MD, PhD; Vijay
Sharma, PhD, """Technetium-complexes for
imaging /j-amyloid in the brain."
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CASE-BASED IMAGING
REVIEW: GASTROINTESTINAL
IMAGING

Mark Mintun, MD, "The
Center for Clinical Imaging
Research at WU."

Christine Menias, MD,
"CT evaluation of nontraumatic abdominal pain."

David Piwnica-Worms,
MD, PhD, "Molecular imaging and high throughput
screening as real time discovery tools in vivo."

Pamela Woodard, MD,
"Read cases with the
experts: abdominal."

Marcus Raichle, MD,
"Neuroimaging at Washington University."

CASE-BASED IMAGING
REVIEW: THORACIC IMAGING

Michael Welch, PhD, "NIH
translational POl and R24
grants supporting imaging
research at WU."

IMAGING SCALES IN
TIME AND SPACE

Fernando Gutierrez, MD,
"MDCT: Principles and
applications in the thorax."

CATEGORICAL COURSE ON
BODY MRI
Marilyn Siegel, MD, "MRI
of bone marrow."

Joseph Culver, PhD,
moderator.
Joseph O'Sullivan, MD,
PhD, "Image reconstruction
as optimal information
extraction."

PUSHING THE LIMITS OF
IMAGING
Steven Petersen, PhD,
"Studying cognitive development and task control in
humans with MRI."

AMERICAN ROENTGEN
RAY SOCIETY

Pamela Woodard, MD,
"MRI of chest pain in the
young"; "Read cases with
the experts: cardiac imaging."

SCIENTIFIC SESSIONS
Pamela Woodard, MD,
"MRI of chest pain in
the young."
Marilyn Siegel, MD, "Pediatric mediastinum: vascular
and nonvascular masses."

INTRODUCTION TO
RESEARCH PROGRAM

106th Annual Meeting
Vancouver; British Columbia
April 'SO—May 5, 2006

Pamela Woodard, MD,
"Research funding
opportunities."

CASE-BASED IMAGING
REVIEW: CARDIOVASCULAR
IMAGING
Sanjeev Bhalla, MD,
"Pericardial disease";
"CT angiography of the
pulmonary arteries."
Cylen Javidan-Nejad, MD,
"Myocardial."
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